Haematology Research Review, Issue 34

In this Issue:

Anticoagulant preferences for cancer-associated thrombosis
Mortality with direct oral anticoagulants
Advanced CLL outcomes after first-line and relapse therapies
Multiple recurrent mutations and relapsed/refractory CLL outcomes
Tamibarotene in relapsed APL
Brentuximab vedotin in mycosis fungoides/S├ęzary syndrome with variable CD30 expression
Brentuximab vedotin for CD30+ cutaneous T-cell lymphoma and lymphomatoid papulosis
Lenalidomide ±rituximab in recurrent follicular lymphoma
Epidemiology and clinical significance of secondary and therapy-related AML

Please login below to download this issue (PDF)

Subscribe